Import Band-Air "For Injection" — Buy in Bulk from Supplier in United Kingdom

The Band-Air "For Injection" from Crown Healthcare Equipment Ltd. is a compact drug delivery interface measuring 2.7 cm x 2.7 cm, designed for subcutaneous, intramuscular, or intravenous injection procedures in clinical and emergency settings. The unit is engineered for precise medication delivery with minimal residual volume, a critical parameter for dose-critical therapeutics such as insulin, vaccines, or biologics. Crown Healthcare Equipment, headquartered in Ruislip, London, positions this device within its portfolio of injection accessories for hospitals, clinics, and outpatient care facilities. The listing references ISO and CE certifications without specifying standards or notified body numbers; buyers should request the exact certificates and their scope of applicability. Material composition, sterility assurance level, and shelf life specifications require direct confirmation from the supplier.

The 2.7 cm x 2.7 cm footprint suggests a single-use adhesive patch or port design intended for attachment to a patient's skin or integration with a drug vial system, though the exact mechanism is not detailed in the source data. Typical injection-grade devices of this form factor employ medical-grade polyurethane or polyethylene terephthalate (PET) substrates with pressure-sensitive silicone or acrylic adhesives, sterilised by gamma irradiation or ethylene oxide. The adhesive must maintain secure attachment through patient movement and moisture exposure while releasing without skin trauma on removal. Crown Healthcare Equipment states the device is manufactured from sterilisable materials, though the specific sterilisation method (autoclave, gamma, ETO, or electron beam) and whether the device is supplied sterile or non-sterile for terminal sterilisation by the end user should be clarified. Biocompatibility testing per ISO 10993 series (cytotoxicity, sensitisation, irritation) is standard for this device class and should be requested.

Target buyers include NHS trusts, private hospital groups, emergency medicine services, and pharmaceutical companies requiring reliable injection platforms for clinical trials or commercial drug delivery. The compact dimensions suit paediatric and geriatric applications where larger adhesive interfaces may cause discomfort or interfere with patient mobility. Importing medical devices from the United Kingdom post-EU exit involves specific regulatory pathways; CE-marked devices remain valid under transitional arrangements, but buyers into the EU should verify UKCA marking status and whether Crown Healthcare Equipment maintains EU authorised representation. Payment terms, minimum order quantities, and lead times are not stated in the available data and must be negotiated directly. The absence of stated unit price or volume tiers means all commercial terms require explicit quotation from the Ruislip office.

Crown Healthcare Equipment Ltd. is located at 2nd Floor, College House, 17 King Edwards Road, Ruislip, London HA4 7AE, United Kingdom. The supplier holds a harbor trust tier with a recorded response rate of 0.00 percent and zero average response hours, indicating limited or untested engagement through the platform channel. Buyers should treat this as an unverified responsiveness profile and initiate direct contact via the Ruislip address or confirmed telephone and email channels to establish communication reliability. No incorporation date, employee count, turnover, or facility details are present in the source data, so company scale and manufacturing versus distribution status must be ascertained through direct inquiry and possible Companies House registry verification in the UK.

The listing describes Crown Healthcare Equipment as serving hospitals, clinics, and healthcare facilities with injection devices, positioning the Band-Air within a medical device portfolio rather than a single-product offering. The reference to ISO and CE certifications without specificity is common in marketplace summaries but insufficient for regulatory procurement; buyers should request ISO 13485 (medical device quality management) registration certificates, CE marking certificates under MDR 2017/745 or applicable MDD transitional provisions, and any FDA 510(k) clearance if US market access is relevant. The London location suggests proximity to UK regulatory and NHS supply chain infrastructure, though whether manufacturing occurs in Ruislip or elsewhere in the UK, Europe, or through contract manufacturing arrangements should be clarified. Due diligence should include requesting reference accounts within comparable healthcare settings and any MHRA registration details.